Positive Phase 2 Data for Subcutaneous Migaldendranib at Angiogenesis 2025
Ashvattha Therapeutics announced positive Phase 2 trial data for its subcutaneously administered nanomedicine, Migaldendranib (MGB), designed to treat retinal...
Rad 101 Detects Brain Metastases in New Clinical Trial
Radiopharm Theranostics announced positive results from a study using a novel imaging approach with RAD 101 (18F-Pivalate) to detect...
Yunu Partnership with WCG and IgniteData Transforms Clinical Trial Imaging
In the dynamic world of clinical trials, Yunu is revolutionizing imaging services with cutting-edge technology and strategic partnerships. Jeffrey...
eGenesis Announces Success: Second Patient Receives Genetically Engineered Porcine Kidney
eGenesis successfully transplanted a genetically modified pig kidney into a second patient with end-stage kidney disease. The procedure, part...
Cyclo Therapeutics’ Positive Phase 3 Open-Label Sub-Study Data in Young Patients
Cyclo Therapeutics presented data from its pivotal Phase 3 TransportNPC™ trial of Trappsol® Cyclo™ for Niemann-Pick Disease Type C1...
Ampligen® & Flumist®: AIM Immunotech’s Innovative Avian Flu Trial
AIM ImmunoTech Inc. is initiating a plan to further develop Ampligen as a vaccine adjuvant for avian influenza. The...
Eylea HD: 3-Year Results Show Durable Vision Gains in Wet AMD
Regeneron announced positive three-year results from an extension study of the Phase 3 PULSAR trial for EYLEA HD (aflibercept...
Carmat Aeson® Artificial Heart Achieves 100 Implants
CARMAT announced it has implanted its Aeson® artificial heart in 100 patients, a significant milestone reached with the 99th...
Zivo and U. Delaware Combat Avian Flu
ZIVO Bioscience is initiating a second collaborative study with the University of Delaware to further investigate the potential of...
Koru Medical’s Next-Gen Subcutaneous Infusion System
KORU Medical Systems has partnered with a global pharmaceutical company to develop and seek regulatory clearance for a next-generation...